IceCure Medical (ICCM) News Today $1.22 0.00 (0.00%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period IceCure Medical CEO Issues Letter to Shareholders & Reports Increase of 42% in ProSense Sales for 2024 in North AmericaJanuary 13, 2025 | finanznachrichten.deIceCure Medical CEO Issues Letter to Shareholders & Reports Increase of 42% in ProSense® Sales for 2024 in North AmericaJanuary 13, 2025 | prnewswire.comThe five-year returns have been enviable for IceCure Medical (NASDAQ:ICCM) shareholders despite underlying losses increasingJanuary 8, 2025 | finance.yahoo.comIceCure Medical Regains Nasdaq Compliance, Securing Market PositionJanuary 7, 2025 | markets.businessinsider.comIceCure Medical regains Nasdaq complianceJanuary 7, 2025 | markets.businessinsider.comIceCure Medical Regains Full Nasdaq Compliance with Nasdaq Minimum Closing Bid Price RuleJanuary 6, 2025 | prnewswire.comIceCure Medical receives Intention to Grant notice from EPOJanuary 4, 2025 | markets.businessinsider.comIceCure Medical: European Patent Office Issues Intention to Grant Notice to IceCure for its Next-Generation Cryoablation TechnologyJanuary 3, 2025 | finanznachrichten.deEuropean Patent Office Issues Intention to Grant Notice to IceCure for its Next-Generation Cryoablation TechnologyJanuary 3, 2025 | prnewswire.comIcecure Medical Appoints New Board Director with Financial ExpertiseDecember 30, 2024 | markets.businessinsider.comIceCure Medical (NASDAQ:ICCM) Shares Down 0.4% - What's Next?IceCure Medical (NASDAQ:ICCM) Shares Down 0.4% - Here's What HappenedDecember 20, 2024 | marketbeat.comData on IceCure's ProSense® Cryoablation for Low-Risk Breast Cancer Presented at Radiological Society of North America's 2024 Annual MeetingDecember 16, 2024 | prnewswire.comIcecure Medical: Strong Growth and Regulatory Momentum Support Buy RatingNovember 27, 2024 | markets.businessinsider.comIcecure Medical’s Strategic Position and Growth Potential Justifies Buy RatingNovember 27, 2024 | markets.businessinsider.comIceCure Medical Sees Strong Growth Amid ProSense® AdoptionNovember 27, 2024 | markets.businessinsider.comIceCure Medical Ltd (NASDAQ:ICCM) Q3 2024 Earnings Call TranscriptNovember 27, 2024 | msn.comIceCure Medical Ltd (ICCM) Q3 2024 Earnings Call TranscriptNovember 26, 2024 | seekingalpha.comIceCure Medical Reports 36% Sales Growth in the First Nine Months of 2024 Driven by Global Adoption of ProSense CryoablationNovember 26, 2024 | finanznachrichten.deIcecure Medical Earnings Review: Q3 SummaryNovember 26, 2024 | benzinga.comIceCure Medical Reports 36% Sales Growth in the First Nine Months of 2024 Driven by Global Adoption of ProSense® CryoablationNovember 26, 2024 | prnewswire.comWhat to Expect from Icecure Medical's EarningsNovember 25, 2024 | benzinga.comIceCure's Next-Generation Multiprobe Cryoablation Technology Issued Notice of Allowance from Japan's Patent OfficeNovember 25, 2024 | prnewswire.comIceCure Medical to Report Third Quarter 2024 Financial & Operational Results on November 26, 2024November 20, 2024 | prnewswire.comIceCure's ProSense® Chosen for Breast Cryoablation Study Led by the Prestigious European Institute of Oncology with Sponsorship from the Italian Ministry of HealthNovember 19, 2024 | prnewswire.comIceCure's ProSense System Gets FDA Panel's Favorable Vote For Low Risk Breast Cancer TreatmentNovember 8, 2024 | markets.businessinsider.comFDA Advisory Panel Votes in Favor of IceCure's ProSense® Cryoablation Benefit-Risk Profile in Early-Stage Low Risk Breast CancerNovember 8, 2024 | prnewswire.comUpcoming FDA Advisory Panel for IceCure's ProSense® Marketing Authorization Receives Large Number of Public Comments from StakeholdersOctober 29, 2024 | prnewswire.comIceCure Medical Expands Patent Portfolio with New US ApprovalOctober 22, 2024 | markets.businessinsider.comIceCure Medical granted patent by USPTO for cryoablation systemOctober 22, 2024 | markets.businessinsider.comIceCure Receives Notice of Allowance from U.S. Patent and Trademark Office for its Next-Generation Cryoablation SystemOctober 21, 2024 | prnewswire.comIcecure Medical: A Strong Buy on Clinical Success and Upcoming Regulatory CatalystsOctober 13, 2024 | markets.businessinsider.comIcecure Medical (NASDAQ:ICCM) Stock Quotes, Forecast and News SummaryOctober 9, 2024 | benzinga.comIcecure Medical (NASDAQ:ICCM) Stock, Short Interest ReportOctober 9, 2024 | benzinga.comIceCure's ProSense® Featured in 6 Global Studies on Cryoablation of Breast Tumors at the 2024 European Society of Breast Imaging ConferenceOctober 7, 2024 | prnewswire.comIceCure's ICE3 5-Year Trial Results Published in the Peer Reviewed Annals of Surgical Oncology Journal: ProSense® Cryoablation Without Excision for Early-Stage, Low-Risk Breast Cancer Demonstrates 96.3% Recurrence Free RateSeptember 24, 2024 | prnewswire.comStudy Published in the British Journal of Radiology Demonstrates IceCure's ProSense® is a Safe Procedure with 97.7% Technical Success Rate in Treating Tumors of the Lung, Bone, and Soft TissuesSeptember 16, 2024 | prnewswire.comIceCure Medical’s ProSense Positioned for Market Success Following FDA Panel Meeting, Analyst Maintains Buy RatingSeptember 13, 2024 | markets.businessinsider.comFDA AdComm to discuss IceCure's ProSense on Nov. 7September 12, 2024 | msn.comIceCure Announces FDA Advisory Panel Meeting Date for Marketing Authorization of ProSense® in Early-Stage Low Risk Breast Cancer Scheduled for November 7, 2024September 12, 2024 | prnewswire.comIceCure to Meet Institutional Investors at the H.C. Wainwright and Lake Street Capital Markets ConferencesSeptember 4, 2024 | prnewswire.comUSPTO Grants Notice of Allowance for Additional Patent on IceCure's Novel Cryogenic Pump Technology: Reinforces IceCure's Global IP Leadership in Cryoablation TechnologiesAugust 28, 2024 | prnewswire.comIcecure Medical Poised for Growth: A Comprehensive Buy RecommendationAugust 22, 2024 | markets.businessinsider.comIcecure Medical: A Strong Buy on Robust Financials and Regulatory AdvancementsAugust 21, 2024 | markets.businessinsider.comIceCure Medical Ltd (NASDAQ:ICCM) Q2 2024 Earnings Call TranscriptAugust 21, 2024 | msn.comIceCure Medical Reports 20% Growth in ProSense® System and Probe Sales for the First Half of 2024; Reflects Continued Adoption in the U.S. and Other Global MarketsAugust 20, 2024 | prnewswire.comIceCure's ProSense® Destroyed 100% of Breast Cancer Tumors in Independent Study of Patients Who Chose Cryoablation Instead of SurgeryAugust 14, 2024 | prnewswire.comIceCure Medical to Report Second Quarter 2024 Financial & Operational Results on August 20, 2024August 13, 2024 | prnewswire.comIceCure Announces Positive Data from the Largest Multi-Institutional Study of its Kind: "Cryoablation of Primary Breast Cancer in Patients Ineligible for Clinical Trials"August 7, 2024 | prnewswire.comIceCure Medical receives Nasdaq compliance noticeJuly 22, 2024 | finance.yahoo.com99.74% Recurrence Free Rate for Women with Breast Cancer Treated with IceCure's ProSense® Cryoablation System: Key Findings Delivered at 32nd Annual Meeting of the Japanese Breast Cancer SocietyJuly 22, 2024 | prnewswire.com Get IceCure Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for ICCM and its competitors with MarketBeat's FREE daily newsletter. Email Address ICCM Media Mentions By Week ICCM Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ICCM News Sentiment▼0.550.44▲Average Medical News Sentiment ICCM News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ICCM Articles This Week▼01▲ICCM Articles Average Week Get IceCure Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for ICCM and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies DRTS News ELMD News ZYXI News INGN News NYXH News RCEL News CATX News PROF News OBIO News LAKE News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ICCM) was last updated on 1/20/2025 by MarketBeat.com Staff From Our PartnersLast time you’ll see this priced at $1.00When was the last time you bought something for a buck? I don’t even think you can buy anything at McDonalds f...StocksToTrade | SponsoredMust-See: 5-Second Trump PredictionPresident Trump's prediction is about to become a reality... Opening a rare window of opportunity for you t...InvestorPlace | SponsoredBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredWarren Buffett Bets $40 Billion—You Can Get in for $20I call it "The Last Retirement Stock You'll Ever Need." Warren Buffett himself owns $40 billion of stock in...Behind the Markets | SponsoredKamala’s final humiliation The investments connected to Trump's second term in ways that almost nobody outside his inner circle is aware ...Porter & Company | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IceCure Medical Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Share IceCure Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
